Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Revenue (2016 - 2025)

Prestige Consumer Healthcare has reported Revenue over the past 16 years, most recently at $283.4 million for Q4 2025.

  • Quarterly results put Revenue at $283.4 million for Q4 2025, down 2.37% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (down 1.31% YoY), and the annual figure for FY2025 was $1.1 billion, up 1.1%.
  • Revenue for Q4 2025 was $283.4 million at Prestige Consumer Healthcare, up from $274.1 million in the prior quarter.
  • Over the last five years, Revenue for PBH hit a ceiling of $296.5 million in Q1 2025 and a floor of $237.8 million in Q1 2021.
  • Median Revenue over the past 5 years was $277.0 million (2022), compared with a mean of $276.1 million.
  • Biggest five-year swings in Revenue: rose 17.34% in 2021 and later decreased 6.59% in 2025.
  • Prestige Consumer Healthcare's Revenue stood at $274.5 million in 2021, then increased by 0.38% to $275.5 million in 2022, then grew by 2.62% to $282.7 million in 2023, then increased by 2.68% to $290.3 million in 2024, then decreased by 2.37% to $283.4 million in 2025.
  • The last three reported values for Revenue were $283.4 million (Q4 2025), $274.1 million (Q3 2025), and $249.5 million (Q2 2025) per Business Quant data.